MENU
LPCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lipocine (LPCN) Ownership - Who owns Lipocine?

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more

Profile

Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.36M
P/E Ratio
N/A
Total Cash
21.63M
Projected Growth
N/A
Total Debt
1.48M
Revenue
11.2M
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash/Share
4.04
Total Debt/Equity
N/A
Revenue/Share
2.07 USD as % of share price

Fundamentals

LPCN
Capitalization
15.4M
P/E Ratio
N/A
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash
21.6M
Total Cash/Share
4.04
Total Debt
1.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.07%
Revenue
11.2M
ROE
N/A
Book Value
21M
P/B Ratio
0.73
Cash Flow
N/A
Earnings
0
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.86K
Current Ratio
14.75
Current Revenue Per Employee
218212.88
Dividends Per Share - Security
N/A
EBITDA
-1.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
-479.60
Revenue To Assets
0.04
Shares Held By Institutions
3.46M
Shares Outstanding - Current
5.35M
Total Liabilities
1.51M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-40.164
View a ticker or compare two or three
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com